Omission of radiotherapy

RADIATION2 trials

Sponsors

The Netherlands Cancer Institute, Antoni van Leeuwenhoek (AVL)

Conditions

Breast CancerBreast cancer

Unknown Phase

DESCARTES trial: De-ESCAlating RadioTherapy in patients with pathologic complete rESponse to neoadjuvant systemic therapy.

RecruitingNL-OMON56100

Antoni van Leeuwenhoek (AVL)Breast cancer

Start: 2022-10-07Target: 595Updated: 2025-09-22

DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy

RecruitingNCT05416164

The Netherlands Cancer InstituteBreast Cancer

Start: 2022-10-07End: 2037-05-31Target: 595Updated: 2025-03-26

Related Papers

ASO Author Reflections: Biopsy Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial

Annals of Surgical Oncology2023-05-18

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study.

2023-03-098 citations